List of insiders holdings for NeuroBo Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| DONG-A ST CO. LTD 10% Owner | 2022-12-29 19:43:44 | 12,429,353 0 | 12,429,353 | Form 13D |
| E&Investment Inc. E&Healthcare Investment Fund II 10% Owner | 2022-08-05 16:25:36 | 6,113,798 0 | 6,113,798 | Form 13D |
| E&Investment Inc. E&Healthcare Investment Fund II E&Healthcare Investment Fund No.7 10% Owner | 2022-08-05 16:25:36 | 6,113,798 0 | 6,113,798 | Form 13D |
| GOLDMAN SACHS GROUP INC GOLDMAN SACHS & CO. LLC 10% Owner | 2022-11-22 16:46:00 | 0 1,220,502 | 1,220,502 | Form 3 |
| Bakshi Akash SVP and COO | 2021-01-05 16:09:02 | 29,013 884,072 | 913,085 | Form 4 |
| Sooch Mina President & CEO | 2017-02-14 16:37:38 | 813,383 0 | 813,383 | Form 13G |
| Lowenschuss David Chief Legal Off. & Secretary | 2017-02-14 14:10:25 | 806,247 0 | 806,247 | Form 13G |
| Kim Hyung Heon CEO & President | 2023-08-14 16:10:40 | 625,064 0 | 625,064 | Form 4 |
| Price Ben Gil CEO and President | 2021-11-04 16:57:38 | 616,666 0 | 616,666 | Form 4 |
| Versavel Mark Chief Medical Officer | 2020-01-02 21:54:16 | 342,930 0 | 342,930 | Form 4 |
| Kim Na Yeon Director 10% Owner | 2023-07-28 06:08:20 | 101,459 200,554 | 302,013 | Form 4 |
| Oniciu Carmen Daniela Vice President | 2016-08-12 12:56:23 | 152,646 0 | 152,646 | Form 4 |
| SASSINE ANDY Director | 2019-07-26 16:38:02 | 151,264 0 | 151,264 | Form 4 |
| Golden Lee Scott Chief Medical Officer | 2018-01-30 16:27:49 | 148,000 0 | 148,000 | Form 4 |
| Reno Seth Chief Commercial Officer | 2019-07-26 16:16:56 | 118,286 0 | 118,286 | Form 4 |
| GROVES JASON L Director | 2023-07-28 06:13:09 | 100,000 0 | 100,000 | Form 4 |
| STRICKLAND D GORDON Director | 2023-07-28 06:15:20 | 100,000 0 | 100,000 | Form 4 |
| Salsbury Michael Director | 2023-07-28 06:17:49 | 100,000 0 | 100,000 | Form 4 |
| KOVEN ANDREW I Director | 2023-07-28 06:19:30 | 100,000 0 | 100,000 | Form 4 |
| LICHTINGER PEDRO Director | 2019-07-26 16:30:59 | 74,833 0 | 74,833 | Form 4 |
| Oh Jeong Gyun Director 10% Owner | 2020-01-15 19:15:33 | 60,000 0 | 60,000 | Form 4 |
| Swirsky Douglas J Director | 2020-09-03 18:48:57 | 60,000 0 | 60,000 | Form 4 |
| Jeong Tae Heum Director | 2020-01-15 19:12:48 | 60,000 0 | 60,000 | Form 4 |
| Gullans Steven R. Ph.D. Director | 2020-01-15 19:11:20 | 60,000 0 | 60,000 | Form 4 |
| Bisgaier Charles PhD Chief Scientific Off. & Chair 10% Owner | 2020-01-10 08:28:40 | 58,012 0 | 58,012 | Form 13D |
| MATHIESEN JEFFREY S Chief Financial Officer | 2018-01-30 16:20:41 | 48,000 0 | 48,000 | Form 4 |
| Glickman Mark A Director | 2023-07-28 06:11:20 | 37,500 0 | 37,500 | Form 4 |
| Woodworth Marshall H Chief Financial Officer | 2024-03-04 21:20:56 | 33,496 0 | 33,496 | Form 4 |
| Tursi James Patrick Director | 2023-12-04 17:12:10 | 32,157 0 | 32,157 | Form 4 |
| KOUSKY KENNETH W Director | 2019-07-26 16:24:40 | 26,935 0 | 26,935 | Form 4 |
| Kang Richard Director | 2022-06-10 17:25:24 | 20,000 0 | 20,000 | Form 4 |
| Hawryluk P. Kent Director | 2018-01-30 16:44:30 | 10,800 0 | 10,800 | Form 4 |
| JK BioPharma Solutions Inc Kang Sun Dae 10% Owner | 2022-09-23 16:20:23 | 0 0 | 0 | Form 13D |
| Hooker Joseph Interim CEO and President | 2023-01-18 16:15:44 | 0 0 | 0 | Form 3 |
| Shannon Nicola VP, Clinical Operations | 2019-12-30 21:31:01 | 0 0 | 0 | Form 3 |